Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Sa1096 High Prevalence of Risk Factors for GI Adverse Effects of Non-Steroidal Anti-Inflammatory Drugs in Rheumatic Patients and Low Adherence to the Administration of Gastroprotective Agents in Latin America: Results of an Observational Study

Autor: Smecuol, Edgardo, Citera, Gustavo, Román, Manuel Robles San, Millan, Alberto J., Lanas, Angel

Publikováno v: In Gastroenterology April 2015 148(4) Supplement 1:S

Spleen Tyrosine Kinase (SYK) negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy.

Autor: Millan AJ; Department of Microbiology and Immunology and the Parker Institute for Cancer Immunotherapy, University of California-San Francisco, San Francisco, CA, USA., Allain V; Department of Medicine, University of California-San Francisco, San Francisco, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Université Paris Cité, INSERM UMR976, Hôpital Saint-Louis, Paris, France., Nayak I; Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Biomedical Sciences Graduate Program, Department of Pediatrics, Pelotonia Institute for Immuno-Oncology, College of Medicine, The Ohio State University, Columbus OH., Aguilar OA; Department of Microbiology and Immunology and the Parker Institute for Cancer Immunotherapy, University of California-San Francisco, San Francisco, CA, USA., Arakawa-Hoyt JS; Department of Microbiology and Immunology and the Parker Institute for Cancer Immunotherapy, University of California-San Francisco, San Francisco, CA, USA., Ureno G; Department of Microbiology and Immunology and the Parker Institute for Cancer Immunotherapy, University of California-San Francisco, San Francisco, CA, USA., Rothrock AG; Department of Medicine, University of California-San Francisco, San Francisco, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Shemesh A; Department of Microbiology and Immunology and the Parker Institute for Cancer Immunotherapy, University of California-San Francisco, San Francisco, CA, USA.; Department of Medicine, University of California-San Francisco, San Francisco, CA, USA., Eyquem J; Department of Medicine, University of California-San Francisco, San Francisco, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Das J; Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Biomedical Sciences Graduate Program, Department of Pediatrics, Pelotonia Institute for Immuno-Oncology, College of Medicine, The Ohio State University, Columbus OH., Lanier LL; Department of Microbiology and Immunology and the Parker Institute for Cancer Immunotherapy, University of California-San Francisco, San Francisco, CA, USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Jul 13. Date of Electronic Publication: 2024 Jul 13.